Editas Medicine EDIT
NASDAQ EDIT
$2.49 -0.02 (-0.80%)
At close: Oct 22, 2026 · 4:00 PM EDT

Editas Medicine (EDIT) Minority Interest (2015)

Updated

Editas Medicine (EDIT) recorded Minority Interest of $280.08 million in Q4 2015.

Analysis

Editas Medicine (EDIT) Minority Interest (2015) Analysis & Trends

  • Across earlier years, Minority Interest came in at $20.77 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Editas Medicine 232.23 Mn -479.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 280.08 Mn
API Access

Editas Medicine Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=EDIT&period=max&api_key=YOUR_API_KEY